VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.9500
-0.0150 (-1.55%)
At close: May 30, 2025, 4:00 PM
0.9949
+0.0449 (4.73%)
After-hours: May 30, 2025, 7:56 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $15.83 million as of May 30, 2025. Its market cap has decreased by -62.29% in one year.
Market Cap
15.83M
Enterprise Value
-34.38M
1-Year Change
-62.29%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $15.83M, a decrease of -93.11%. That is a compound annual growth rate of -40.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 15.83M | -67.96% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |